中華調研網歡迎您!聯系我們 | 英文版 | 網站地圖

2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

http://www.reports.tw  2012-09-12  中華調研網  關閉窗口

  Chapter One Synthesis Polypeptide Drug Industry Overview 1

  1.1 Synthesis Polypeptide Drug Definition 1

  1.2 Synthesis Polypeptide Drug Classification and Application 3

  1.3 Professional Terms Interpretation 8

  1.4 Synthesis Polypeptide Drug Industry Chain Structure 12

  1.5 Synthesis Polypeptide Drug Industry Overview 14

  Chapter Two Synthesis Polypeptide Drug International and China Market Analysis 16

  2.1 Synthesis Polypeptide Drug Industry International Market Analysis 16

  2.1.1 Synthesis Polypeptide Drug International Market Development History 16

  2.1.2 Synthesis Polypeptide Drug Product and Technology Developments 18

  2.1.3 Synthesis Polypeptide Drug Competitive Landscape Analysis 25

  2.1.4 Synthesis Polypeptide Drug International Key Countries Development Status 28

  2.1.5 Synthesis Polypeptide Drug International Market Development Trend 30

  2.2 Synthesis Polypeptide Drug China Market Analysis 33

  2.2.1 Synthesis Polypeptide Drug China Market Development History 33

  2.2.2 Synthesis Polypeptide Drug Product and Technology Developments 33

  2.2.3 Synthesis Polypeptide Drug Competitive Landscape Analysis 35

  2.2.4 Synthesis Polypeptide Drug China Key Regions Development Status 37

  2.2.5 Synthesis Polypeptide Drug China Market Development Trend 37

  2.3 Synthesis Polypeptide Drug International and China Market Comparison Analysis 42

  Chapter Three Major Synthesis Polypeptide Drug Analysis 43

  3.1 Immunity Regulating Medicine (Allergy Infection and Immune) 43

  3.1.1 Glatiramer Injection (Glatiramer Acetate) 43

  3.1.2 Thymalfasin for Injection 46

  3.1.3 Thymopentin Injection 49

  3.1.4 Thymopetidum Injection 53

  3.1.5 Summary 55

  3.2 Digestive System Drugs (Gastrointestinal Type) 57

  3.2.1 Octreotide Acetate Injection 57

  3.2.2 Somatostatin for Injection 61

  3.3 Bone and Connective Tissue Types (Thyroid hormones Drug) 66

  3.3.1 Salmon Calcitonin Injection 67

  3.3.2 Elcatonin Injection 70

  3.3.4 TerfparaLide Injectlon 72

  3.4 Gynecologic or Obstetric Drug 76

  3.4.1 Oxytocin Injection 76

  3.4.2 Carbetocin Injection 81

  3.4.3 Acetate Atosiban Injection 83

  3.5 Tumor Drug (hCG) 86

  3.5.1 Leuprorelin Acetate Microspheres for Injection 87

  3.5.2 Goserelin Acetate 89

  3.5.3 Triptorelin Acetate Injection 92

  3.5.4 Chorionic Gonadotrophin for Injection 95

  3.6 Urinary System Drug (Diabetes Insipidus) 98

  3.6.1 Desmopressin Acetate Injection 98

  3.6.2 Terlipressin for Injection 101

  3.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents) 105

  3.7.1 Biosynthetic Glucagon for Injection 105

  3.7.2 Exenatide Injection 106

  Chapter Four Synthesis Polypeptide Drug Development Environmental Analysis 109

  4.1 China‘s Macroeconomic Environment Analysis 109

  4.1.1 China GDP Analysis 109

  4.1.2 China CPI Analysis 111

  4.2 European Economic Environmental Analysis and Impact 113

  4.3 United States Economic Environmental Analysis and Impact 116

  4.4 Japan Economic Environmental Analysis and Impact 119

  4.5 Global Economic Environmental Analysis and Impact 120

  4.5.1 Global Economic Environmental Analysis 120

  4.5.2 Global Economic Influence 121

  Chapter Five Synthesis Polypeptide Drug Development Policy and Plan 121

  5.1 China Government Policy and Development Plan 121

  5.2 Industry Policy and Standard 122

  5.3 Technical Standard 125

  5.4 Technology Replacement and R&D Trends 126

  5.5 Hotspots and Influence 127

  Chapter Six Synthesis Polypeptide Drug Manufacturing Process and Cost Structure 132

  6.1 Synthesis Polypeptide Drug Manufacturing Process Overview 132

  6.2 Synthesis Polypeptide Drug Manufacturing Process Analysis 135

  6.3 Synthesis Polypeptide Drug Cost Structure Analysis 138

  Chapter Seven 2009-2013 Synthesis Polypeptide Drug Productions Supply Sales Demand Market Status and Forecast 140

  7.1 2009-2013 Synthesis Polypeptide Drug Capacity Production Overview 140

  7.1.1 2009-2013 Global and China Synthesis Polypeptide Drug Capacity Production 140

  7.1.2 2009-2013 Synthesis Polypeptide Drug Production Market Share 146

  7.1.3 2009-2013 Synthesis Polypeptide Drug Demand Overview 152

  7.1.4 2009-2013 Synthesis Polypeptide Drug Supply Demand and Shortage 152

  7.1.5 2009-2013 Synthesis Polypeptide Drug Production Import Export Consumption 153

  7.1.6 2009-2013 Synthesis Polypeptide Drug Cost Price Production Value Gross Margin 154

  7.2 Different Type Synthesis Polypeptide Drug Sales and Market Scale Analysis 156

  7.2.1Thymopentin Injection 156

  7.2.2 Thymalfasin Injection 158

  7.2.3 Calcitonin Injection 159

  7.2.4 Somatostatin for Injection 161

  7.2.5Octreotide Acetate Injection 162

  7.2.6 Desmopressin Acetate Injection 163

  7.3 Synthesis Polypeptide Drug Market Summary 165

  Chapter Eight Synthesis Polypeptide Drug Key Manufacturers 170

  8.1 Novartis 170

  8.2 Merck Serono 176

  8.3 Ferring Pharmaceuticals 181

  8.4 Ipsen PHarma Biotech 188

  8.5 Lilly 191

  8.6Asahi Kasei 195

  8.7 AstraZeneca 199

  8.8 SciClone Pharmaceuticals 203

  8.9 Takeda 206

  8.10 HYBIO Pharmaceutical Co.,Ltd (Shenzhen Stock:300199) 210

  8.11 Hainan Zhonghe Pharmaceutical Co.,Ltd 215

  8.12 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd 219

  8.13 Beijing Yingu Century Pharmaceutical Co.,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co.,Ltd) 224

  8.14 Hainan Shuangcheng Pharmaceuticals Co.,Ltd 227

  8.15 Livzon Pharmaceuticals Co.,Ltd (Livzon:000513) 234

  8.16 Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd 238

  8.17 Chengdu Tiantaishan Pharmaceutical Co.,Ltd 242

  8.18 Beijing Shuanglu Pharmaceutical Co.,Ltd 250

  8.19 Yangzijiang Pharmaceutical Co.,Ltd 257

  8.20 Changzhou Siyao Pharmaceutical Co.,Ltd 262

  Chapter Nine Up and Down Stream Industry Analysis and Influence 267

  9.1 Upstream Raw Materials Price Analysis and Influence 267

  9.1 Upstream Equipments Market Analysis and Influence 269

  9.3 Downstream Demand Analysis and Influence 270

  9.4 Industry Policy Analysis and Influence 271

  Chapter Ten Synthesis Polypeptide Drug Marketing Channels Analysis 272

  10.1 Synthesis Polypeptide Drug Marketing Channels Status 272

  10.1.1 Drugs Marketing Channel Developemnt History 272

  10.1.1 Prescription Drug Marketing Development Status 273

  10.2 Synthesis Polypeptide Drug Marketing Channels Management 274

  10.3 Synthesis Polypeptide Drug Marketing Channels Establishment 275

  10.4 Synthesis Polypeptide Drug Marketing Channels Development Trend 276

  Chapter Eleven Synthesis Polypeptide Drug Industry Development Trend 278

  11.1 2012-2016 Synthesis Polypeptide Drug Industry Development Trend 278

  11.2 2012-2016 Market Potential Forecast 279

  11.3 2012-2016 R&D Trend 280

  11.3.1Polypeptide Drug Technical Development Status 280

  11.3.2 Polypeptide Drug and Health Care Products Research and Manufacturing Overview 282

  11.3.3 China Polypeptide Drug Development Direction and Prospect 283

  11.4 2012-2016 Marketing Channels Change Trend 285

  14.4.1 Prescription Drug Marketing Channels Change Trend 285

  14.4.2 Prescription Drug Sales Method Five Trend 286

  11.5 2012-2016 Competition Pattern Development Trends 288

  Chapter Twelve Synthesis Polypeptide Drug Industry Development Proposals 289

  12.1 Macroeconomic Development Countermeasures 289

  12.2 New Firms Enter Market Strategy 290

  12.2.1 New Business Entry Barriers 290

  12.2.2 New Corporate Strategy 290

  12.3 New Project Investment Proposal 293

  12.4 Marketing Channel Strategy Proposals 294

  12.5 Competitive Environment Strategy Proposals 296

  12.5.1 Competitive Environment Analysis 296

  12.5.2 Strategy Proposals 297

  Chapter Thirteen Synthesis Polypeptide Drug New Project Investment Feasibility Analysis 300

  13.1 Synthesis Polypeptide Drug Project SWOT Analysis 300

  13.2 Synthesis Polypeptide Drug New Project Investment Feasibility Analysis 302

  13.2.1 Buildings 302

  13.2.2 Investment 303

  13.2.3 Project Schedule 303

  13.2.4 Project Investment Return and Feasibility Analysis 304

  Chapter Fourteen Synthesis Polypeptide Drug Industry Research Conclusions 304

  Tables and Figures

  Figure Synthesis Polypeptide Process Flow 1

  Figure Synthesis Polypeptide Drug Picture-Thymopentin Injection 2

  Figure Polypeptide Applications on Health Care Food and Cosmetics Fields 4

  Figure Polypeptide Drug Manufacturing Process Method 4

  Table Synthesis Polypeptide Drug Classification and Application List 5

  Table Synthesis Polypeptide Drug Product Name Use and Annual Sales Revenue (USD) List 6

  Table Listed Polypeptide Drug Name Type Indication 6

  Figure Pharmaceutical Industry Value Chain Structure 12

  Figure Pharmaceutical Industry Industry Chain Structure 12

  Figure Synthesis Polypeptide Drug Industry Chain Structure 13

  Figure Synthesis Polypeptide Drug Industrialization System 13

  Figure 2000-2011 China Pharmaceutical Industry Sales Revenue and Total Profit (100 Million RMB) and Growth Rate 14

  Figure 2007-2015 China Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 15

  Figure DNA Transcribed into RNA Diagram 17

  Figure RNA Translated into Polypeptide Chains Molecular Diagram 18

  Table Polypeptide Drug Three Manufacturing Methods 19

  Figure 1984 Chemistry Nobel Prize Winner Robert Bruce Merrifield 20

  Figure Polypeptide Solid Phase Synthesis Principle 20

  Figure Solid Phase Polypeptide Synthesis 21

  Figure United States CS Three Channel Full Automatic Polypeptide Synthetic Instrument 22

  Figure Homemade CS136 Model Research Polypeptide Synthetic Instrument 23

  Figure Large Scale Liquid Phase Synthesis of Polypeptide 24

  Figure Thin Film Evaporator (for perishable goods Concentration) 24

  Table Global 2008 Revenue More than 1 Billion Polypeptide Drug Brands List 25

  Table Some Listed Polypeptide Drug Indication Classification 26

  Figure Listed Polypeptide Drug Indication Classification Market Share 26

  Figure 2004-2014 Global Pharmaceutical Sales Revenue (Billion USD) and Growth Rate 30

  Figure 2009-2013 International Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 31

  Table 2011 Some Polypeptide Drug Global Sales Revenue (100 Million USD) 31

  Figure Each Year Enter Clinical Research Polypeptide Drug Quantity (Piece) 32

  Table 17 Emerging Pharmaceutical Market Sizes (Billion USD) 38

  Figure 2007-2015 China Pharmaceutical Sales Revenue (100 Million USD) 39

  Figure 2009-2015 China Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 39

  Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 40

  Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Proportion of China Total Polypeptide Drug Market Scale 41

  Figure 2007-2009 China Chemical Synthesis Polypeptide Drug Types Market Share 41

  Table Copaxone Neuron Structure Diagram 44

  Table Thymalfasin for Injection (Thymalfasin a1) Suppliers List 48

  Table 2010 Thymalfasin for Injection Key Products Price (RMB/Piece) List 49

  Table Some Thymopentin Injection Suppliers List 51

  Table Thymopentin Injection Hospital Purchase Price (RMB/Piece) List 52

  Table Thymopetidum Injection Thymopentin Injection Thymalfasin Injection Comparison 56

  Table Octreotide Acetate Injection Key Suppliers List 59

  Table 2012 Hebei Province Octreotide Acetate Injection Bid Price List 60

  Tale Somatostatin for Injection Key Suppliers List 64

  Table Somatostatin for Injection Key Products Hospital Average Purchae Price List 64

  Table 2012 Hebei Province Somatostatin for Injection Key Suppliers List 65

  Table Salmon Calcitonin Injection Suppliers List 69

  Table Salmon Calcitonin Injection/Nasal Spray Products Hospital Purchase Price List 69

  Table Salmon Calcitonin Injection/Nasal spray Products Retail Price List 70

  Table Elcatonin Injection Key Suppliers and Product Selling Price List 72

  Figure TerfparaLide Injectlon-Forsteo Injection Pen Parts 75

  Table 2011Q1 China Some Aproved New Drug Number, Specifications Suppliers and Indication 76

  Table 2012 New Add Key Monitoring Drug Table--TerfparaLide Injectlon 76

  Table Oxytocin Injection Key Suppliers List 78

  Table Oxytocin Injection Suppliers Products Models List 80

  Table Carbetocin Injection Suppliers List 83

  Table Acetate Atosiban Injection Supplier Product Specification Price List 85

  Table Leuprorelin Acetate Microspheres for Injection Suppliers Product Specification Price List 88

  Table Triptorelin Acetate Injection Suppliers Product Specification Price List 94

  Table Chorionic Gonadotrophin for Injection Suppliers Product Specifications List 97

  Table 2011 Some Hormone Drugs Independent Pricing and Uniform Pricing Comparison 98

  Table Desmopressin Acetate Injection Key Suppliers List 100

  Table Desmopressin Acetate Injection Key Suppliers Forms Product Specifications and Bid Price List 101

  Table Terlipressin for Injection Key Brands Manufacturers and Retail Prices 104

  Table Biosynthetic Glucagon for Injection Suppliers and Retail Prices List 106

  Table Exenatide Suppliers Product Specifications Retail Prices List 109

  Figure 2007-2015 China Medical Industry Total Production Value (100 Million RMB) and Growth Rate 110

  Table 2006-2011 China GDP (1000 Million RMB) and Growth Rate 110

  Figure 2007-2011 China Medical Industry Total Value and Its Proportion of China Total GDP 111

  Figure 2007-2015 China Individual Medical Expenditure (RMB) 112

  Figure 2007-2015 China Health Expenditure Per Capita and National Medical Expenditure Comparison 112

  Figure 2011-2016 China Population Growth and Aging Condition 113

  Figure 2006-2011 Europe Several Countries PMI Trend 114

  Figure United States CPI and PCE Growth Comparison 117

  Figure United States Private Savings Rate Change and Net Export /GDP Proportion Change Trend 118

  Figure United States Public Debt and Deficit Proportion of GDP 119

  Figure Japan GDP and CPI Growth Rate Comparison 119

  Figure 2009-2011 China Health Capital Investment (100 Million RMB) 122

  Table China Pharmaceutical Industry All major Departments and Regulatory Functions 122

  Table Pharmaceutical Industry main Laws and Regulations and Policies 125

  Table 2009-2012 China Medical and Health System Reform Important Policy 128

  Table 2009-2012 China Related Pharmaceutical Product Quality Supervision Policy 129

  Table 2008-2012 China Development and Reform Commission Policy on Drug Price Management Policies 130

  Figure PTIPolypeptide Synthetic Instruments Picture 133

  Table Synthesis Polypeptide Drug Technology Processes List 133

  Figure Polypeptide Pharmaceutical Raw Materials Manufacturing Process Flow 135

  Figure Freeze Dried Powder Injection Manufacturing Process Flow 136

  Figure Small Capacity Injection Manufacturing Process Flow 136

  Figure Thymalfasin API Manufacturing Process Flow 137

  Figure Thymalfasin Injection Manufacturing Process Flow 138

  Figure International Synthesis Polypeptide Drug Cost Structure 139

  Table 2009-2011 China Synthesis Polypeptide Drug Cost Structure 139

  Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Capacity and Total Capacity (10K Piece) List 140

  Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Capacity Market Share List 140

  Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Production and Total Production (10K Piece) List 141

  Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Production Market Share List 141

  Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Capacity and Total Capacity (10K Piece) List 142

  Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Capacity Market Share List 142

  Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Production and Total Production (10K Piece) List 143

  Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share List 143

  Figure 2009-2013 Global Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 144

  Table 2009-2013 Global Synthesis Polypeptide Drug Capacity Utilization Rate List 144

  Figure 2009-2013 China Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 145

  Table 2009-2013 China Synthesis Polypeptide Drug Capacity Utilization Rate List 145

  Table 2009-2013 Key Manufacturers Synthesis Polypeptide Drug China Sales (10K Piece) Top20 List 146

  Table 2009-2013 Key Manufacturers Synthesis Polypeptide Drug China Sales Top20 Market Share List 147

  Table 2010 Key Manufacturers Synthesis Polypeptide Drug China Sales Revenue (100 Million RMB) Top10 List 147

  Table 2008-2010 Key Manufacturers Synthesis Polypeptide Drug China Sales Revenue Top10 Market Share List 148

  Figure 2011 Key Manufacturers Synthesis Polypeptide Drug China Sales Market Share 149

  Figure 2012 Key Manufacturers Synthesis Polypeptide Drug China Sales TOP20 Market Share 150

  Figure 2011 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share 151

  Figure 2012 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share 151

  Table 2009-2013 Global Synthesis Polypeptide Drug Demand (10K Piece) and Growth Rate 152

  Table 2009-2013 China Synthesis Polypeptide Drug Demand (10K Piece) and Growth Rate 152

  Table 2009-2013 China Synthesis Polypeptide Drug Supply Demand and Shortage (10K Piece) 153

  Table 2009-2013 Nine Foreign Enterprises Synthesis Polypeptide Drug China Sales (10K Piece) List 153

  Table 2009-2013 China Synthesis Polypeptide Drug Production Import Export Consumption (10K Piece) List 154

  Table 2007-2009 China Synthesis Polypeptide Drug Price (RMB/Piece) Distribution 154

  Table 2009-2011 Hainan Shuangcheng Pharmaceuticals Some Synthesis Polypeptide Drug Price Cost (RMB/Piece) Gross Margin List 155

  Table 2009-2013 China Synthesis Polypeptide DrugProduction (10K Piece) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 155

  Figure 2011 China Synthesis Polypeptide Drug Market Share by Different Type Drug 156

  Figure 2008-2014 China Thymopentin Injection Market Scale (100 Million RMB) and Growth Rate 157

  Figure 2008-2014 China Thymopentin Injection Sales (10K Piece) and Growth Rate 157

  Figure 2008-2014 China Thymalfasin Injection Market Scale (100 Million RMB) and Growth Rate 158

  Figure 2008-2014 China Thymalfasin Injection Sales (10K Piece) and Growth Rate 159

  Figure 2008-2014 China Calcitonin Injection Market Scale (100 Million RMB) and Growth Rate 160

  Figure 2008-2014 China Calcitonin Injection Sales (10K Piece) and Growth Rate 160

  Figure 2008-2014 China Somatostatin for Injection Market Scale (100 Million RMB) and Growth Rate 161

  Figure 2008-2014 China Somatostatin for Injection Sales (10K Piece) and Growth Rate 162

  Figure 2008-2014 China Octreotide Acetate Injection Market Scale (100 Million RMB) and Growth Rate 163

  Figure 2008-2014 China Octreotide Acetate Injection Sales (10K Piece) and Growth Rate 163

  Figure 2008-2014 China Desmopressin Acetate Injection Market Scale (100 Million RMB) and Growth Rate 164

  Figure 2008-2014 China Desmopressin Acetate Injection Sales (10K Piece) and Growth Rate 164

  Table 2009-2011 China Chemical Synthesis Polypeptide Drug Injection Distribution List 165

  Figure 2010 Global Polypeptide Drug Market Structure by Treatment Class 165

  Table Research or Listed Polypeptide Drugs List 166

  Figure 1990-2010 China Resident Three Types of Chronic Disease Prevalence (1/100K) Change Trend 167

  Figure 2010 China Synthesis Polypeptide Drug Hospital Terminal Sales Market Share Distribution 168

  Figure 2010 China Synthesis Polypeptide Drug Top10 Manufacturers Sales Revenue (100 Million RMB) 168

  Figure China Synthesis Polypeptide Drug Prices Distribution 169

  Figure Use Me-Too Model Developed Polypeptide Drug List 169

  Table Novartis Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 170

  Figure Novartis China Market Sales Synthesis Polypeptide Drug--Octreotide Acetate Injection 173

  Figure Novartis China Market Sales Synthesis Polypeptide Drug--Somatostatin Acetate for Injection 173

  Figure Novartis China Market Sales Synthesis Polypeptide Drug--salmon Calcitonin Nasal Spray 174

  Table 2009-2013 Novartis Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 174

  Figure 2009-2013 Novartis Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 175

  Table Merck Serono Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 176

  Figure Merck Serono Synthesis Polypeptide Drug--Recombinant Human Follitropin Alfa Solution for Injection 178

  Figure Merck Serono Synthesis Polypeptide Drug--Somatostatin for Injection 179

  Figure Merck Serono Synthesis Polypeptide Drug--Gonadorelin for Injection 179

  Table 2009-2013 Merck Serono Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 180

  Figure 2009-2013 Merck Serono Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 181

  Table Ferring Pharmaceuticals Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 182

  Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Minirin 183

  Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Decapeptyl 184

  Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Pentasa 184

  Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Glypressin 185

  Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Octostim 186

  Table 2009-2013 Ferring Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 186

  Figure 2009-2013 Ferring Pharmaceuticals Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 188

  Table Ipsen PHarma Biotech Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 188

  Figure Ipsen PHarma Biotech Synthesis Polypeptide Drug--Triptorelin Acetate for Injection 190

  Table 2009-2013 Ipsen PHarma Biotech Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 190

  Figure 2009-2013 Ipsen PHarma Biotech Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 191

  Table Lilly Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 192

  Figure Lilly Some China Listed Synthesis Polypeptide Drug List 194

  Table 2009-2013 Lilly Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 194

  Figure 2009-2013 Lilly Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 195

  Table Asahi Kasei Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 195

  Figure Asahi Kasei Synthesis Polypeptide Drug--Elcatonin Injection 198

  Table 2009-2013 Asahi Kasei Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 198

  Figure 2009-2013 Asahi Kasei Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 199

  Table AstraZeneca Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 199

  Figure AstraZeneca China Selling Synthesis Polypeptide Drug-Goserelin Acetate Slow Release Implantation Agent 201

  Table 2009-2013 Jiangsu AstraZeneca Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 202

  Figure 2009-2013 Jiangsu AstraZeneca Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 203

  Table SciClone Pharmaceuticals Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 204

  Figure SciClone Pharmaceuticals Synthesis Polypeptide Drug-- Thymopetidum α1 Injection 205

  Table 2009-2013 SciClone Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 205

  Figure 2009-2013 SciClone Pharmaceuticals Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 206

  Table Takeda Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 206

  Figure Takeda--Leuprorelin Acetate Microspheres for Injection 208

  Table 2009-2013 Takeda Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 209

  Figure 2009-2013 Takeda Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 209

  Table HYBIO Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 210

  Figure 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug 211

  Table 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 213

  Figure 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 215

  Table Hainan Zhonghe Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 216

  Figure Hainan Zhonghe Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug産品 217

  Table 2009-2013 Hainan Zhonghe Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 217

  Figure 2009-2013 Hainan Zhonghe Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 219

  Table Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 219

  Figure Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug-Thymalfasin Injection 221

  Figure Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 222

  Table 2009-2013 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 222

  Figure 2009-2013 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 223

  Table Beijing Yingu Century Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 224

  Figure Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Salmon Calcitonin Nasal Spray 225

  Figure Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 226

  Table 2009-2013 Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 226

  Figure 2009-2013 Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 227

  Table Hainan Shuangcheng Pharmaceuticals Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 228

  Figure Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug--Thymalfasin Injection(基泰) 229

  Figure Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for Injection 231

  Figure Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection (雙成可維) 232

  Table 2009-2013 Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 233

  Figure 2009-2013 Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 234

  Table Livzon Pharmaceuticals Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 234

  Figure Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug 236

  Table 2009-2013 Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 236

  Figure 2009-2013 Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 238

  Table Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 239

  Figure Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug--Thymopentin Injection 240

  Figure Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug--Somatostatin for Injection 240

  Table 2009-2013 Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 241

  Figure 2009-2013 Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 242

  Table Chengdu Tiantaishan Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 242

  Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for Injection 244

  Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 246

  Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Octreotide Acetate Injection 247

  Table 2009-2013 Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 248

  Figure 2009-2013 Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 249

  Table Beijing Shuanglu Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 250

  Figure Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 251

  Figure Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Salmon Calcitonin Injection 252

  Table Beijing Shuanglu Pharmaceutical Co.,Ltd Thymopentin Injection Price List 253

  Table 2009-2013 Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 256

  Figure 2009-2013 Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 257

  Table Yangzijiang Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 257

  Figure Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for Injection 259

  Figure Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 260

  Table 2009-2013 Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 260

  Figure 2009-2013 Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 261

  Table Changzhou Siyao Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 262

  Figure Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug List 264

  Table Changzhou Siyao Pharmaceutical Co.,Ltd Chemical Pharmaceutical Raw Materials List 264

  Table Changzhou Siyao Pharmaceutical Co.,Ltd Chemical Raw Materials Intermediates List 265

  Table 2009-2013 Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 266

  Figure 2009-2013 Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 266

  Table Synthesis Polypeptide Drug Project Key Equipments and Price (10K RMB) 269

  Table Synthesis Polypeptide Drug Project Equipments List and Price (10K RMB) 270

  Table Drugs Manufacturing Enterprise Specialized Academic Promotion Organization Frame 276

  Figure Synthesis Polypeptide Drug Industry Entry Barriers List 293

  Table 2012 China Synthesis Polypeptide Drug New Project SWOT Analysis 300

  Table 2012 China Synthesis Polypeptide Drug New Project Buildings List 302

  Table 2012 China Synthesis Polypeptide Drug New Project Investments (10K RMB) List 303

  Table Synthesis Polypeptide Drug New Project Investment Return and Feasibility Analysis 304


本文地址:http://www.reports.tw/english/3588.html
本文來源:中華調研網
分享到:
相關Synthesis Polypeptide Drug報告
關于Synthesis Polypeptide Drug資訊